MedPath

Identification of TT Cases by Community Treatment Assistants: An Assessment

Not Applicable
Completed
Conditions
Trichiasis
Interventions
Other: TT Training Program and TT Screening Card
Registration Number
NCT01783743
Lead Sponsor
Johns Hopkins University
Brief Summary

To achieve the goal of trachoma control as mandated by the World Health Organization, countries must reduce the backlog of trichiasis surgery cases to less than 1/1,000 of their population. However, these cases reside in rural villages in trachoma endemic districts, and finding them to offer services is a challenge. Community Treatment Assistants (CTAs) are village residents who are trained to offer Mass Drug Administration (MDA) to their communities and hence are in contact with most residents. A training guide and tool for screening for trachomatous trichiasis (TT) will be developed to train CTAs in rural Tanzania to identify cases in their communities and refer them to surgery. Compared to the current process by which CTAs passively screen for TT if cases complaint, investigators hypothesize that the trained CTAs will identify twice the usual number of TT surgery cases during ongoing community antibiotic administrations for trachoma and will also miss fewer cases. If this simple system is effective, it can be implemented widely to screen communities for cases of TT.

Residents from thirty-six villages holding MDA, for whom a complete census is available, will be randomized on a 1:1 basis to intervention (where the CTAs receive the enhanced training from the enhanced training team) and usual assessment (where the CTAs receive the usual instructions from the regular MDA team). In both arms, the CTAs will keep records of all cases they have screened as positive for TT amongst the residents.

A Master TT grader will grade all screened cases of TT to determine the rate of true positivity in both arms.In addition, he will examine a random sample of residents who are screened as negative to detect potentially missed cases and estimate the total burden of trichiasis cases in both arms as well.The assessments of the Master TT grader will serve as the gold standard for calculations of sensitivity, specificity, and positive and negative predictive values of the enhanced training versus usual assessment methods.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
27473
Inclusion Criteria
  • All persons in the study and control communities are eligible for the MDA.
  • Adults aged 15 and over will be eligible for the survey and re-assessment.
  • Those who are screened positive in the re-assessment will be eligible for treatment at the surgery camp.
  • Those who are screened positive for TT initially but refuse the definitive re-screening will still be offered surgery but told they may not have TT and will be re-screened by the surgeon.
Exclusion Criteria
  • none

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention armTT Training Program and TT Screening CardCommunity treatment assistants (CTA ) will receive usual training, including the basic background of trachoma/trichiasis recognition, drug administration, and azithromycin dosing. In addition to the usual training, these CTA's will also receive an additional modest half day training for TT case recognition which is called the TT training program and TT Screening Card to help them identify TT cases and refer them for surgery.
Primary Outcome Measures
NameTimeMethod
TT Cases Screened Positive by CTA's and Confirmed by Graders10 months

All the TT cases detected in control versus intervention arms (adjusted for population size) through screening were verified by graders.

Grader re-graded all these cases except for the cases lost to follow-up.

Secondary Outcome Measures
NameTimeMethod
Specificity of TT Screening Methods10 months

Specificity of different TT screening methods compared to "true" assessment of cases and controls using the extrapolated values from the follow-up survey.

Formula used: True negatives/(true negatives +false positive)

Positive Predictive Values of TT Screening Methods10 months

Positive Predictive Values (PPV) of the different screening methods compared to "true" assessment of cases and controls.

It was calculated by using extrapolated values. The formula used: True positives /total participants at initial screening screened as positive by CTA's.

Negative Predictive Values of TT Screening Methods10 months

Negative Predictive Values (NPV) of the different screening methods compared to "true" assessment of cases and controls.

It was calculated by using extrapolated values. Formula used : True Negatives /total participants at initial screening,screened as negative by CTA's

Sensitivity of TT Screening Methods10 months

Sensitivity of different TT screening methods compared to "true" assessment of cases and controls using the extrapolated values from the follow-up survey.

Formula used: True positives/(true positives +false negative)

Trial Locations

Locations (1)

Johns Hopkins University

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath